Enlighten
Research publications by members of the University of Glasgow
home > services > Enlighten

Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance

Donaldson, C., Hundley, V., and McIntosh, E. (1996) Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance. Health Economics, 5 (3). pp. 267-269. ISSN 1057-9230

Full text not currently available from Enlighten.

Abstract

When drafting protocols for the use of economic evaluation alongside clinical trials, it is common to have to specify which type of economic evaluation is going to be carried out. Will it be a cost-benefit analysis (CBA), cost-effectiveness analysis (CEA) or a cost-utility analysis (CUA)? It is our contention that prior specification of the appropriate economic technique is not possible, in the majority of cases, until data on effectiveness and cost are actually available. In this letter, we aim to demonstrate the thinking behind our contention and to illustrate this with two case studies; one of a recent randomised trial, the other of a trial currently in progress.

Item Type:Article
Status:Published
Refereed:Yes
Glasgow Author(s):McIntosh, Dr Emma
Authors: Donaldson, C., Hundley, V., and McIntosh, E.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Health Economics and Health Technology Assessment
Journal Name:Health Economics
ISSN:1057-9230
ISSN (Online):1099-1050
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record